News
LCT announces share purchase plan
December 29, 2006
Living Cell Technologies (ASX:LCT)
announced today that it has established a share purchase plan to
advance the clinical trial program for its DiabeCell product.
Under the share purchase plan, each eligible shareholder who holds
shares in LCT at the record date of 10 January 2007 may purchase up
to $5,000 worth of new fully paid ordinary shares, regardless of the
number of LCT shares they currently hold, utilising Class Order 02/831
issued by the Australian Securities & Investments Commission.
Related Document
Download ( =
23.8Kb )
|